9,627,640 Shares of Common Stock 28,084 Shares of Series B Preferred Stock Viridian Therapeutics, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • August 19th, 2022 • Viridian Therapeutics, Inc.\DE • Services-medical laboratories • New York
Contract Type FiledAugust 19th, 2022 Company Industry Jurisdiction